Feature Hidden Data Putting GlaxoSmithKline to the test over paroxetine BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6754 (Published 12 November 2013) Cite this as: BMJ 2013;347:f6754 Article Related content Metrics Responses Peer review Data supplement Web Extra Correspondence relating to data requests for study 329 Files in this Data Supplement: Data Supplement Related articles Feature The rules of retraction Published: 07 December 2010; BMJ 341 doi:10.1136/bmj.c6985 News GSK backs campaign for disclosure of trial data Published: 07 February 2013; BMJ 346 doi:10.1136/bmj.f819 Letter Weighing up non-clinical factors when choosing drugs Published: 04 December 2013; BMJ 347 doi:10.1136/bmj.f7161 Feature From promises to policies: is big pharma delivering on transparency? Published: 26 February 2014; BMJ 348 doi:10.1136/bmj.g1615 Research Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence Published: 16 September 2015; BMJ 351 doi:10.1136/bmj.h4320 See more An adolescent with disabling abdominal pain BMJ December 07, 2016, 355 i6101; DOI: https://doi.org/10.1136/bmj.i6101 Maternal deaths from suicide must be tackled, say experts BMJ December 07, 2016, 355 i6585; DOI: https://doi.org/10.1136/bmj.i6585 Andrew Wakefield calls Trump “on our side” over vaccines after meeting BMJ December 05, 2016, 355 i6545; DOI: https://doi.org/10.1136/bmj.i6545 Electronic fetal monitoring, cerebral palsy, and caesarean section: assumptions versus evidence BMJ December 01, 2016, 355 i6405; DOI: https://doi.org/10.1136/bmj.i6405 Clinical commissioning groups will be rated on sepsis care BMJ November 25, 2016, 355 i6361; DOI: https://doi.org/10.1136/bmj.i6361 Cited by... Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescenceAbstract Fulltext PDF From promises to policies: is big pharma delivering on transparency?Abstract Fulltext PDF Weighing up non-clinical factors when choosing drugsAbstract Fulltext PDF
